Aripiprazole--data on efficacy and associated mortality.

Aripiprazole--data on efficacy and associated mortality.

Bibliografske podrobnosti
Glavni avtor:	Crow, T
Format:	Journal article
Jezik:	English
Izdano:	2007

Podobne knjige/članki

Aripiprazole as protector against COVID-19 mortality
od: C. Loucera-Muñecas, et al.
Izdano: (2024-05-01)

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
od: Izchak Kohen, et al.
Izdano: (2010-03-01)

Aripiprazole – therapeutic efficacy and safety in everyday practice
od: Karina Nowakowska, et al.
Izdano: (2019-12-01)

The use of aripiprazole in early onset schizophrenia: safety and efficacy
od: Ibrahim, Normala, et al.
Izdano: (2009)

Aripiprazol e síndrome de Tourette Aripiprazole and Tourette syndrome
od: Ana Hounie, et al.
Izdano: (2004-09-01)

Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin
od: Akito Kawai, et al.
Izdano: (2022-08-01)

Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
od: Fagiolini Andrea
Izdano: (2010-04-01)

Urinary retention in male patient associated with aripiprazole
od: Lara Utku Ince, et al.
Izdano: (2016-12-01)

Aripiprazole-associated tic in a schizophrenia patient
od: Guo X, et al.
Izdano: (2015-03-01)

Aripiprazole cardiosafety: Is it overestimated?
od: Ahmed Naguy
Izdano: (2016-01-01)

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
od: Vieta Eduard, et al.
Izdano: (2009-07-01)

Is the use of Aripiprazole effective for the management of irritability and behavioral symptoms in adolescents with Prader Willi Syndrome?: a case report Efficacy of Aripiprazole in a case with PWS
od: Jorgelina Stegmann, et al.
Izdano: (2019-11-01)

Covert dyskinesia associated with aripiprazole: A case report
od: Shih- Cheng Chang, et al.
Izdano: (2019-01-01)

Aripiprazole in schizophrenia: consensus guidelines.
od: Travis, M, et al.
Izdano: (2005)

Aripiprazole-induced transient myopia
od: Tongabay Cumurcu, et al.
Izdano: (2020-10-01)

Review of depot aripiprazole for schizophrenia
od: Motiwala FB, et al.
Izdano: (2013-11-01)

Aripiprazole-induced skin rash
od: Santanu Nath, et al.
Izdano: (2016-01-01)

Aripiprazole for late-life schizophrenia
od: Jeffrey Rado, et al.
Izdano: (2010-08-01)

Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia
od: Saki Hattori, et al.
Izdano: (2023-03-01)

Guagueira induzida por aripiprazol e tratada com risperidona Aripiprazole-induced stuttering treated with risperidone
od: Felipe Filardi da Rocha
Izdano: (2009-12-01)

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
od: Nastaran Habibi, et al.
Izdano: (2015-11-01)

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders
od: Cox JH, et al.
Izdano: (2016-06-01)

Aripiprazole alone or in combination for acute mania.
od: Brown, R, et al.
Izdano: (2013)

Improving the Solubility of Aripiprazole by Multicomponent Crystallization
od: Qi Zhou, et al.
Izdano: (2021-03-01)

Aripiprazol and Hypersexuality: when partial is to much
od: P. Espada-Santos, et al.
Izdano: (2022-06-01)

Aripiprazole for acute mania in an elderly person
od: Balaji Bharadwaj, et al.
Izdano: (2011-01-01)

Schizophrenia: effects of aripiprazole in metabolic syndrome
od: Deborah Galvão Coelho da Silva, et al.
Izdano: (2019-11-01)

In vivo anti-Toxoplasma activity of aripiprazole
od: Mehrzad Saraei, et al.
Izdano: (2015-09-01)

Aripiprazole-induced obsessive-compulsive symptoms
od: Chun Lin, et al.
Izdano: (2020-01-01)

Worsened hypertension control induced by aripiprazole
od: Yasui-Furukori N, et al.
Izdano: (2013-04-01)

Aripiprazole reduces liver cell division.
od: Tinkara Pirc Marolt, et al.
Izdano: (2020-01-01)

Role of aripiprazole in treatment-resistant schizophrenia
od: Mossaheb N, et al.
Izdano: (2012-05-01)

Cardiovascular risk associated with chronic treatment of paliperidone, olanzapine, risperidone and aripiprazole
od: A. L. Montejo, et al.
Izdano: (2024-04-01)

Acute Angle-closure Glaucoma Associated with Aripiprazole: A Case Report
od: Rashmi Vishwanath, et al.
Izdano: (2024-05-01)

Use of aripiprazole in an obsessive compulsive disorder case with associated motor tics
od: A. Alvarado Dafonte, et al.
Izdano: (2022-06-01)

Efficacy and Side Effects of Aripiprazole and Olanzapine in Patients with Psychotic Disorders: A Randomized Controlled Trial
od: Nima Ghitoli, et al.
Izdano: (2023-09-01)

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
od: Madera JJ, et al.
Izdano: (2019-06-01)

Efficacy of aripiprazole combined with olanzapine for hospitalized male patients with schizophrenia and its effect on metabolic syndrome
od: Liu Shunhua, et al.
Izdano: (2024-06-01)

Solubility Behaviour of Aripiprazole in Different Solvent Systems
od: Sharda Sambhakar, et al.
Izdano: (2024-01-01)

Adolescent Catatonia Successfully Treated with Lorazepam and Aripiprazole
od: Aaron J. Roberto, et al.
Izdano: (2014-01-01)